Frequency and impact of somatic co-occurring mutations on post-transplant outcomes in acute myeloid leukemia: a multicenter registry analysis on behalf of the EBMT ALWP


Por: Bazarbachi, A, Galimard, JE, Abou Dalle, I, Labopin, M, Sanz, J, Huang, H, Mayer, J, Solano, C, Lioure, B, Griskevicius, L, Maertens, J, Itälä-Remes, M, Kaare, A, Gallego-Hernanz, MP, Bug, G, Ribera, JM, Gadisseur, A, Schmid, C, Kwon, M, Poiré, X, Coccia, P, Chacon, MJ, Baron, F, Craddock, C, Brissot, E, Nagler, A, Ciceri, F and Mohty, M

Publicada: 1 mar 2026 Ahead of Print: 1 dic 2025
Resumen:
Acute myeloid leukemia (AML) includes genetically defined subsets. In allogeneic hematopoietic cell transplantation (allo-HCT), the frequency and prognosis of gene-gene interactions may differ from those of patients treated with chemotherapy alone. In this study, adult patients (N = 952) with AML allografted between 2015 and 2023, with available next generation sequencing (NGS) at diagnosis were included. Most frequent mutations were DNMT3A (24%), FLT3-ITD (21%), NPM1 (21%), RUNX1 (16%), NRAS (16%), TET2 (14%), and IDH2 (12%). Multiple correspondence analysis identified distinct groups of co-occurring mutations. Outcome analysis was performed on 646 AML patients allografted in first complete remission (CR1). Six non-overlapping groups were constructed: 1) TP53 mutation (N = 47); 2) NPM1 mutation (N = 129); 3) FLT3-ITD and/or DNMT3A mutation (N = 128); 4) SRSF2 and/or ASXL1 and/or RUNX1 mutation (SAR group) (N = 132); 5) IDH1 and/or IDH2 and/or TET2 mutation (N = 43); and 6) all ten genes unmutated (N = 167). In multivariable analysis, TP53 mutation, adverse karyotype, and age negatively affected leukemia-free survival (LFS) and overall survival (OS). OS was additionally negatively affected when the ten genes were unmutated. Notably, outcomes were excellent for SAR mutations (2-year LFS 76%, OS 84%), indicating allo-HCT in CR1 can overcome their adverse risk at diagnosis.

Filiaciones:
Bazarbachi, A:
 Amer Univ, Beirut Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon

Galimard, JE:
 Sorbonne Univ, St Antoine Hosp, AP HP,EBMT Paris Study Unit, Rheumatol Dept,INSERM,UMRs 938, F-75012 Paris, France

Abou Dalle, I:
 Amer Univ, Beirut Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon

Labopin, M:
 Sorbonne Univ, St Antoine Hosp, AP HP,EBMT Paris Study Unit, Rheumatol Dept,INSERM,UMRs 938, F-75012 Paris, France

Sanz, J:
 Univ Valencia, Hosp Univ & Politecn La Fe, Hematol Dept, CIBERONC,Valencia Dept Med,Inst Carlos III, Madrid, Spain

Huang, H:
 Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kunming, Peoples R China

Mayer, J:
 Univ Hosp Brno, Brno, Czech Republic

Solano, C:
 Univ Valencia, Hosp Clin Univ, INCLIVA, Valencia, Spain

Lioure, B:
 Hop Univ Strasbourg, Hematol Oncol Dept, Strasbourg, France

Griskevicius, L:
 Vilnius Univ Hosp, Santaros Klin, Vilnius, Lithuania

 Vilnius Univ, Vilnius, France

Maertens, J:
 Univ Hosp Gasthuisberg, Leuven, Belgium

Itälä-Remes, M:
 Turku Univ Hosp, Turku, Finland

Kaare, A:
 Tartu Univ Hosp, Tartu, Estonia

Gallego-Hernanz, MP:
 Univ Hosp Poitiers, Hematol Oncol & Cellular Therapy Dept, Poitiers, France

Bug, G:
 Goethe Univ Frankfurt, Frankfurt Main, Germany

:
 ICO Hosp Univ Germans Trias i Pujol, Josep Carreras Res Inst, Badalona, Spain

Gadisseur, A:
 Antwerp Univ Hosp UZA, Antwerp, Belgium

Schmid, C:
 Augsburg Univ Hosp, Augsburg, Germany

 Med Fac, Augsburg, Germany

Kwon, M:
 Hosp Gen Univ Gregorio Maranon, Dept Hematol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain

Poiré, X:
 Clin Univ St Luc, Brussels, Belgium

Coccia, P:
 Azienda Osped Riuniti Ancona, Ancona, Italy

Chacon, MJ:
 Hosp Univ Virgen de Las Nieves, Granada, Spain

Craddock, C:
 Queen Elizabeth Hosp, Blood & Marrow Transplant Unit, Birmingham, England

Brissot, E:
 Hop St Antoine, Serv Hematol & Malad Sang, Paris, France

Nagler, A:
 Chaim Sheba Med Ctr, Hematol Div, Tel Hashomer, Israel

Ciceri, F:
 Univ Vita Salute, IRCCS Osped San Raffaele, Haematol, Milan, Italy

 BMT, Milan, Italy

Mohty, M:
 Sorbonne Univ, St Antoine Hosp, AP HP, Rheumatol Dept,Inserm,UMRs 938, Paris, France
ISSN: 02683369





Bone Marrow Transplantation
Editorial
Nature Publishing Group, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 61 Número: 3
Páginas: 282-293
WOS Id: 001630594500001
ID de PubMed: 41345260
imagen Green Accepted

MÉTRICAS